Ergomed earnings boosted by 'significant' profit growth in second half

Writer, Stock Market Wire
Thursday, January 31, 2019 - 10:07

Pharmaceutical services provider Ergomed said Thursday annual earnings were expected to meet market expectations on the back of cost cuts and a 'significant' turnaround in profits seen in the second half.

Net Service fee revenues for 2018 were expected to be approximately £46.5m, up from £39.6m, in line with current market expectations, the company said.

Growth in both pharmacovigilance and CRO was anticipated to be broadly in line with expectations.

New business sales rose to £76m for the year, from £54m a year earlier, bolstering the Ergomed's order book. The backlog of orders at the end of 2018 was expected to be approximately £106m, up from £88m a year earlier.

'Based on our contracted backlog and re-aligned cost base, I am optimistic we can deliver our 2019 growth targets,' said Dr Miroslav Reljanovic, Executive Chairman of Ergomed.

At 10:07am: (LON:ERGO) Ergomed Plc share price was +2.5p at 175p


Related content

Ergomed reports wider losses amid writedown of Haemostatix business

Pharmaceutical services provider Ergomed reported a wider loss for the year as the writedown of its Haemostatix business offset a strong performance in its services...

Wed, 10/04/2019 - 07:47


Ergomed industry appoints Roy Ovel as Chief Commercial Officer

Pharmaceutical services provider Ergomed industry appointed Roy Ovel as Chief Commercial Officer with immediate effect.

Roy would join Ergomed's Executive team and be responsible for...

Mon, 01/04/2019 - 08:18


Ergomed CFO Stuart Jackson to step down

Ergomed, a pharmaceutical industry supplier, said Wednesday Stuart Jackson would be stepping down as Chief Financial Officer in the summer this year.

The move comes...

Wed, 13/02/2019 - 10:18


Broker Forecast - Numis issues a broker note on Ergomed Plc

Numis today upgrades its investment rating on Ergomed Plc (LON:ERGO) to add (from hold) and cut its price target to 190p (from 250p).

Broker Forecasts...

Wed, 19/09/2018 - 10:40


Ergomed swings to loss as delays to projects bite

Ergomed swung to a first-half loss Wednesday as performance was impacted by delays to the start of some contracts and reductions in scope by sponsors...

Wed, 19/09/2018 - 10:12